You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
白雲山(00874.HK):旗下3家涉虛擡藥價企業負責人已免職或停職處理
廣州白雲山(00874.HK)(600332.SH)公佈,公司得悉國家醫療保障局網站發佈通報,已採取一系列整改措施。公司已經責成白雲山製藥總廠、天心製藥和敬修堂藥業停止與相關代理商、經銷商的合作,全面整改營銷模式,在全國範圍進行相關產品降價或撤網,對違規操作的行爲絕不袒護,堅決處理,並已經對三家企業相關負責人予以免職或停職處理。 今後,公司將堅決貫徹落實國家關於深化醫藥衛生體制改革的部署和政策,監督及督促下屬企業規範營銷模式,主動規範自身經營行爲,自覺維護藥品流通秩序,依法依規做好生產經營工作。 公司董事會認爲,該通報對公司未來產品銷售會產生一定影響,但不會對經營業務產生重大不良影響。 國家醫保局發佈通報,對白雲山(00874.HK)(600332.SH)旗下天心製藥、白雲山製藥總廠及敬修堂藥業等三家企業藥品虛高定價、套取資金進行專項調查,責令三家企業及關聯企業全面整改營銷模式,對涉案人員,有關部門正在依紀依法查處。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account